Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | ALPL | P05186 | 1/20 | 0.47 |
| ▸ | ALPG | P10696 | 1/20 | 0.47 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.40 |
| ▸ | SLC22A4 | Q9H015 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 4/20 | 0.31 |
| ▸ | CPT2 | P23786 | 1/20 | 0.30 |
| ▸ | CPT1A | P50416 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5866870 | 0.86 | POLB (0.44) | POLBALPLALPGBBOX1SLC22A4 | |
| SCHEMBL6155809 | 0.81 | POLB (0.47) | POLBALPLALPGBBOX1SLC22A4 | |
| SCHEMBL109859 | 0.81 | TSHR (0.52) | POLBALPLALPGBBOX1SLC22A4 | |
| SCHEMBL14744262 | 0.78 | GABRR1 (0.36) | POLBALPLALPGBBOX1TSHR | |
| SCHEMBL22479145 | 0.78 | GABRR1 (0.36) | POLBALPLALPGBBOX1TSHR | |
| SCHEMBL1005600 | 0.77 | POLB (0.48) | POLBALPLALPGBBOX1SLC22A4 | |
| SCHEMBL17763259 | 0.77 | CA2 (0.50) | POLBALPLALPGBBOX1CYP3A4 | |
| SCHEMBL45428 | 0.77 | POLB (0.44) | POLBALPLALPGBBOX1SLC22A4 | |
| SCHEMBL16432634 | 0.77 | POLB (0.44) | POLBALPLALPGBBOX1SLC22A4 | |
| SCHEMBL4894577 | 0.76 | CA1 (0.55) | POLBALPLALPGCYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112240173-B | Foam circulation-based oil-gas well sand washing method, defoaming liquid for oil-gas well sand washing and foaming liquid | 中国石油化工股份有限公司 | 2023-06-02 | — | — | CN | claimed |
| CN-112240173-A | Oil and gas well sand washing and well flushing method based on foam circulation, and defoaming solution and foaming solution for oil and gas well sand washing and well flushing | 中国石油化工股份有限公司 | 2021-01-19 | — | — | CN | claimed |
| WO-2024046834-A1 | ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS | ANALYTICON DISCOVERY GMBH (DE) | 2024-03-07 | — | — | WO | disclosed |
| WO-2023175129-A1 | ADDITIVE FOR SUNSCREENS | SYMRISE AG (DE) | 2023-09-21 | — | — | WO | disclosed |
| US-20230202967-A1 | COMPOSITIONS AND METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE | GAVISH-GALILEE BIO APPLICATIONS LTD. (IL) | 2023-06-29 | — | — | US | disclosed |
| CN-112240173-B | Foam circulation-based oil-gas well sand washing method, defoaming liquid for oil-gas well sand washing and foaming liquid | 中国石油化工股份有限公司 | 2023-06-02 | — | — | CN | disclosed |
| CN-115466406-A | PH-UCST response type lignin-based zwitterionic compound, preparation method thereof and method for recovering cellulase at room temperature | 华南理工大学 | 2022-12-13 | — | — | CN | disclosed |
| WO-2022128052-A1 | MEDICAMENT FOR FIGHTING INFLAMMATORY CONDITIONS OF HUMAN SKIN | SYMRISE AG (DE) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022128054-A1 | MEDICAMENT FOR FIGHTING INFLAMMATORY CONDITIONS OF HUMAN SKIN (IV) | SYMRISE AG (DE) | 2022-06-23 | — | — | WO | disclosed |
| CN-112240173-A | Oil and gas well sand washing and well flushing method based on foam circulation, and defoaming solution and foaming solution for oil and gas well sand washing and well flushing | 中国石油化工股份有限公司 | 2021-01-19 | — | — | CN | disclosed |
| CN-111621369-A | Neutral environment-friendly water-based cleaning agent for high-end integrated circuit board and preparation method thereof | 中山翰华锡业有限公司 | 2020-09-04 | — | — | CN | disclosed |
| CN-101790458-A | Method for making a lithographic printing plate | AGFA GRAPHICS NV | 2010-07-28 | — | — | CN | disclosed |
| CN-101389476-B | Method for making lithographic printing plate | AGFA GRAPHICS NV | 2010-06-23 | — | — | CN | disclosed |
| CN-101389476-A | Method for making lithographic printing plate | AGFA GRAPHICS NV (BE) | 2009-03-18 | — | — | CN | disclosed |
| US-20080182960-A1 | Surface-crosslinked latex particulates | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2008-07-31 | — | — | US | disclosed |
| CN-1930525-A | Stable high pH developer | KODAK POLYCHROME GRAPHICS GMBH (DE) | 2007-03-14 | — | — | CN | disclosed |
| WO-2001039735-A1 | CONDITIONING SHAMPOO COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-06-07 | — | — | WO | disclosed |
| EP-0417559-A2 | Silicone emulsions | BAYER AG (DE) | 1991-03-20 | — | — | EP | disclosed |
| EP-0079206-B1 | PROCESS FOR PRODUCING 5-HALOMETHYLFURFURAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-02-19 | — | — | EP | disclosed |
| EP-0079206-A1 | Process for producing 5-halomethylfurfural | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-05-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230202967-A1 | COMPOSITIONS AND METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE | DGAT2, DGAT1, LCAT | POLB 1394/4885ALPL 1439/4885ALPG 2385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.